Citation: Rj. Briscoe et al., A catalytic antibody against cocaine attenuates cocaine's cardiovascular effects in mice: a dose and time course analysis, INT IMMUNO, 1(6), 2001, pp. 1189-1198
Citation: Cg. Zhan et Dw. Landry, Theoretical studies of competing reaction pathways and energy barriers foralkaline ester hydrolysis of cocaine, J PHYS CH A, 105(8), 2001, pp. 1296-1301
Authors:
Kuhar, MJ
Carroll, FI
Bharat, N
Landry, DW
Citation: Mj. Kuhar et al., Anticocaine catalytic antibodies have no affinity for RTI compounds: Implications for treatment, SYNAPSE, 41(2), 2001, pp. 176-178
Authors:
Koetzner, L
Deng, SX
Sumpter, TL
Weisslitz, M
Abner, RT
Landry, DW
Woods, JH
Citation: L. Koetzner et al., Titer-dependent antagonism of cocaine following active immunization in rhesus monkeys, J PHARM EXP, 296(3), 2001, pp. 789-796
Citation: Cg. Zhan et al., Energy barriers for alkaline hydrolysis of carboxylic acid esters in aqueous solution by reaction field calculations, J PHYS CH A, 104(32), 2000, pp. 7672-7678
Authors:
Gold, JA
Cullinane, S
Chen, J
Oz, MC
Oliver, JA
Landry, DW
Citation: Ja. Gold et al., Vasopressin as an alternative to norepinephrine in the treatment of milrinone-induced hypotension, CRIT CARE M, 28(1), 2000, pp. 249-252
Citation: Tj. Baird et al., Natural and artificial enzymes against cocaine. I. Monoclonal antibody 15A10 and the reinforcing effects of cocaine in rats, J PHARM EXP, 295(3), 2000, pp. 1127-1134
Authors:
Morales, DLS
Gregg, D
Helman, DN
Williams, MR
Naka, Y
Landry, DW
Oz, MC
Citation: Dls. Morales et al., Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock, ANN THORAC, 69(1), 2000, pp. 102-106
Citation: Cg. Zhan et al., Theoretical studies of fundamental pathways for alkaline hydrolysis of carboxylic acid esters in gas phase, J AM CHEM S, 122(7), 2000, pp. 1522-1530
Citation: Cg. Zhan et al., Reaction pathways and energy barriers for alkaline hydrolysis of carboxylic acid esters in water studied by a hybrid supermolecule-polarizable continuum approach, J AM CHEM S, 122(11), 2000, pp. 2621-2627
Authors:
Argenziano, M
Chen, JM
Cullinane, S
Choudhri, AF
Rose, EA
Smith, CR
Edwards, NM
Landry, DW
Oz, MC
Citation: M. Argenziano et al., Arginine vasopressin in the management of vasodilatory hypotension after cardiac transplantation, J HEART LUN, 18(8), 1999, pp. 814-817
Authors:
Morales, D
Madigan, J
Cullinane, S
Chen, J
Heath, M
Oz, M
Oliver, JA
Landry, DW
Citation: D. Morales et al., Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock, CIRCULATION, 100(3), 1999, pp. 226-229
Authors:
Rosenzweig, EB
Starc, TJ
Chen, JM
Cullinane, S
Timchak, DM
Gersony, WM
Landry, DW
Galantowicz, ME
Citation: Eb. Rosenzweig et al., Intravenous arginine-vasopressin in children with vasodilatory shock aftercardiac surgery, CIRCULATION, 100(19), 1999, pp. 182-186
Authors:
Chen, JM
Cullinane, S
Spanier, TB
Artrip, JH
John, R
Edwards, NM
Oz, MC
Landry, DW
Citation: Jm. Chen et al., Vasopressin deficiency and presser hypersensitivity in hemodynamically unstable organ donors, CIRCULATION, 100(19), 1999, pp. 244-246
Authors:
Argenziano, M
Chen, JM
Choudhri, AF
Cullinane, S
Garfein, E
Weinberg, AD
Smith, CR
Rose, EA
Landry, DW
Oz, MC
Citation: M. Argenziano et al., Management of vasodilatory shock after cardiac surgery: Identification of predisposing factors and use of a novel pressor agent, J THOR SURG, 116(6), 1998, pp. 973-980